Mjung Kwon

Title: Mjung Kwon: Innovator in Cancer Treatment

Introduction

Mjung Kwon is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. His work focuses on developing methods to inhibit tumor growth and angiogenesis, which are critical in the fight against cancer.

Latest Patents

Mjung Kwon holds a patent for "Filipil compositions and methods for treating cancer." This patent includes a purified DOC1 polypeptide that comprises a fragment of SEQ ID NO: 1. The invention provides methods for inhibiting angiogenesis and tumor growth by administering a nucleic acid encoding a DOC1 polypeptide. This allows cells in the subject to produce the DOC1 polypeptide, thereby inhibiting both angiogenesis and tumor growth. He has 1 patent to his name.

Career Highlights

Mjung Kwon works for the United States of America, as Represented by the Secretary, Department of Health and Human Services. His role in this esteemed organization highlights his commitment to advancing healthcare and cancer treatment through innovative research.

Collaborations

Mjung Kwon has collaborated with notable colleagues such as Steven K Libutti and Anita Tandle. These partnerships have likely contributed to the success of his research and the development of his patented methods.

Conclusion

Mjung Kwon's contributions to cancer treatment through his innovative patents demonstrate his dedication to improving health outcomes. His work continues to inspire advancements in medical research and treatment methodologies.